Member Info for hopeabound

Me as well. A few small ones.

Sounds like a storm in a teacup to me. We are still over one month away from the timeframe stated by the CEO.

Naturally, any delay will impact SP and would require explanation. Until such point...

Framing one's opinion of the CEO as love him or hate is a bit strange. I don't have either feeling. I do respect what work he has done and and how far they have come. I also appreciate the benefit their work will do for so many people's lives. Not many on this board can say that of themselves, It is easy to criticise but really 'Lifestyle Company Directors', even if you do not think it, then why put it?

The company has taken a long time to get to this point, proven their tech works, improved a drug that will benefit many. I am sure the process leading to such a deal is methodical - not only in the exchange of data but the details of the deal itself. That said, as it is in advanced talks, data being exchanged, they will have an agreement in principle. You may say you are posting without emotion but you are using emotive text such as love him or hate him and 'Lifestyle Company Directors'. Really?

Anyway, I am invested here and based on all the information I have read, this company is set to do very well. I certainly hope so for all invested.

ATrades - what twaddle. Betting odds are based on something real. What are you basing 100/1 on? The CEO has confirmed they are in advanced talks. The tech has been proven. The data is being gone over. The need is massive. The company that we think is a preferred partner know the drug and its commercial benefits. In the words of the great Ricky Tomlinson, 100/1 my arse.

Your random predictions include:
26 Feb 2020 - Personally I have written off this investment . It’s like a 100/1 shot they pull off a deal.
13 Feb 2020 - Currently eating words....
13 Feb 2020 - more TR1’s incoming. 4 p Friday
06 Feb 2020 - nxp002 is the bigger deal here. It’s worked out a right treat I believe. Easily double from here, advanced negotions !! Jeez I’m now a ramper
30 Dec 2019 - I believe we will be back up to 14’s
28 Dec 2019 - I’ll be happy with 20p come April.

Hi Plums. that's interesting then. It was a presumption on my part, in response to whether the new man Keegan would be playing a part. Any information you are able to impart, I am sure, will be universally well received.

I don't think Karl Keegan will have anything to do with the outcome of the NXP002 deal. It is already at an advanced stage and I presume being carried out by a healthcare division of a bank, who will have control of that and presumably would not take kindly to someone coming in at this stage and suggesting things. Whoever has carried out the negotiations thus far, Dan is happy with. Not long now.

And 13:16 918,378 unknown

15:45 2 x 250,000
17:07 300,000

Showing as sells - Be great for the seller to diminish

The words of the CEO, someone with 18 years’ experience in commercialisation and business development within the pharmaceutical industry and a PHD in Chemistry. NXP002 is indeed technical and may or may not happen within Q1. But who do I trust? Dan with all his knowledge who built the company up and understands exactly what point we are at or some faceless poster, whose contribution to life is er...what exactly. Claims to have no holding and says DYOR as if that means anything. Dan vs Brooko. Not really a competition is it.

NXP001 – impacted by coronavirus but ‘We still expect these funds to come in’

NXP002 – ‘Really pleased with where things are. We want to get the best deal because I believe the outcome will be transformational for the business’

NXP002 I am still really happy with the way that negotiation is going and I am still hopeful that it will close in Q1

Finances: ‘We are very comfortable right now with the small raise we did before Christmas, and ongoing income we have with Ebers activities allows us to progress both NXP002 and NXP004 programmes without delay or reliance on third parties’

‘We’ve got a fantastic team, we’ve got some wonderful assets…the whole team feels that there is tremendous value in the business and we are all highly incentivised to take things forward.’

‘Our technology is proven, we’ve been able to reduce that to practice in clinic, which validates the rest of the growing portfolio.’

#NFX ‘To be able to bring him (Karl Keegan) onto the team at this time is absolutely perfect for us. He’s got an excellent track record in delivering value across a range of capital markets life science companies and we’re really looking forward our sleeves up with him as we go forward over the next couple of months’.

https://twitter.com/VoxPodcast/status/1229721742555439104

Looking forward to this interview to see what Dan has to say regarding Japan and his thoughts on the new appointment.

Thanks Yorkshireboy. Informative and that is what is great about this company. Truly, life-changing drugs that are quick to clinic, and commercially significant. That's why they are in advanced talks and why when the deal happens this will fly.

Investor1111 - there is no absolute that it is the ex-ceo - there has been a seller for a while.

https://www.linkedin.com/in/karl-keegan-b0185510/

Indeed, exciting reminder.

Have registered. Cheers.

mt80 - thanks for going to that effort

Good post goupplease - so much happening. Once the dust settles on this - there is much to look forward to.

Taff and Brooke are frankly disgusting.

Well, there has certainly been a number of trying news releases and an inevitable impact on the share price. I agree Sparkington, Dan is not really in a position to say anything and when asked previously has said NXP002 is in process. Well, we wait for news on new Team members and of course NXP002 as well as NXP4, Ebers, etc...I would have thought he is not having the best of weeks and will be keen to draw a line under the latest issues, so I look forward to positive news soon to return the share upwards.

Don't know. Good question. We will know by tomorrow.

The Different Types of Patent Status according to - https://www.inquartik.com/inq-patent-legal-status/ - the third one is relevant to what you have highlighted, which is the patent can now be monetised!!!!

The Patent Statuses can first be grouped into four macro-categories:

Pending — The patent application was submitted to the patent office but no final decision has been made yet.
PGPub – Granted — The patent application has been made available to the public (generally 18 months after filing).
Active — The patent has been granted and its owner can now enforce or monetize it according to its strategy.
Inactive — The patent can’t be enforced or monetized anymore.